Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02165176 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT02165176: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT02165176 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02165176, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
Few studies have been conducted to assess the pharmacokinetic and pharmacodynamic effects of orally consumed intact cannabis (e.g., cannabis-containing brownies). Careful analysis of oral cannabis dose effects on these parameters is required to determine the level and duration of biological cannabinoid exposure and associated subjective, cardiovascular and cognitive effects. In the present study we evaluated the detection of cannabinoids in oral fluid, plasma, hair, and urine for up to 9 days following consumption of oral cannabis (10mg, 25mg, or 50mg THC). The outcomes of the study will extend scientific knowledge about the behavioral pharmacology and toxicology of oral cannabis administration and can inform policies regarding clinical, workplace and roadside drug testing programs.
Interventions
- DRUG Oral cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02165176
The ClinicalTrials.gov registry entry for NCT02165176 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral cannabis is the first listed.
NCT02165176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02165176 about?
NCT02165176 is a clinical study titled "Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis". Few studies have been conducted to assess the pharmacokinetic and pharmacodynamic effects of orally consumed intact cannabis (e.g., cannabis-containing brownies). Careful analysis of oral cannabis dose effects on these parameters is required to determine the level and duration of biological cannabin...
What is the current status of trial NCT02165176?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2014-06. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02165176?
The interventions under investigation include: Oral cannabis (DRUG).
Who is sponsoring clinical trial NCT02165176?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.